Concepedia

Christopher Kurzatkowski

CK

Statistics

Publications

4

Citations

260

H-Index

4

Active since

2018

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Christopher Kurzatkowski is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and oncogenes.

Publications per year

2018–2021

4

Publications

4

Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14–mutant Non–small Cell Lung Cancer

Ken Suzawa, Michael Offin, Daniel Lu et al. · Clinical Cancer Research · 2018 · 120 citations

, , +15

Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers

Morana Vojnic, Daisuke Kubota, Christopher Kurzatkowski et al. · Journal of Thoracic Oncology · 2019 · 97 citations · Full text

, , +12

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers

Igor Odintsov, Marissa S. Mattar, Allan J.W. Lui et al. · Journal of Thoracic Oncology · 2021 · 31 citations · Full text

, , +16

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

Takuo Hayashi, Igor Odintsov, Roger S. Smith et al. · Disease Models & Mechanisms · 2020 · 12 citations · Full text

, , +17

1–4 of 4